Beam Therapeutics, Inc. (BEAM)
29.66
+0.20
(+0.68%)
USD |
NASDAQ |
Sep 04, 16:00
30.36
+0.70
(+2.36%)
After-Hours: 20:00
Beam Therapeutics SG&A Expense (TTM) : 125.40M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 125.40M |
| March 31, 2026 | 120.31M |
| December 31, 2025 | 113.82M |
| September 30, 2025 | 110.20M |
| June 30, 2025 | 109.97M |
| March 31, 2025 | 112.74M |
| December 31, 2024 | 111.52M |
| September 30, 2024 | 126.12M |
| June 30, 2024 | 125.02M |
| March 31, 2024 | 120.05M |
| December 31, 2023 | 116.81M |
| September 30, 2023 | 96.24M |
| June 30, 2023 | 92.64M |
| March 31, 2023 | 92.05M |
| December 31, 2022 | 87.80M |
| September 30, 2022 | 82.90M |
| Date | Value |
|---|---|
| June 30, 2022 | 76.86M |
| March 31, 2022 | 66.20M |
| December 31, 2021 | 57.22M |
| September 30, 2021 | 47.80M |
| June 30, 2021 | 39.53M |
| March 31, 2021 | 33.07M |
| December 31, 2020 | 29.60M |
| September 30, 2020 | 27.41M |
| June 30, 2020 | 25.40M |
| March 31, 2020 | 23.44M |
| December 31, 2019 | 20.55M |
| September 30, 2019 | 18.10M |
| June 30, 2019 | 15.45M |
| March 31, 2019 | 10.47M |
| December 31, 2018 | 6.545M |
| September 30, 2018 | 2.834M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Twist Bioscience Corp. | 290.29M |
| Prime Medicine, Inc. | 54.39M |
| Intellia Therapeutics, Inc. | 136.25M |
| Sana Biotechnology, Inc. | 44.71M |
| Sarepta Therapeutics, Inc. | 436.74M |